547 related articles for article (PubMed ID: 30238130)
1. Cannabidiol modulation of antinociceptive tolerance to Δ
Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol-Δ
Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
[TBL] [Abstract][Full Text] [Related]
4. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
Wakley AA; Wiley JL; Craft RM
Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
6. Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.
Craft RM; Britch SC; Buzitis NW; Clowers BH
Exp Clin Psychopharmacol; 2019 Aug; 27(4):338-347. PubMed ID: 31120286
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat.
Wakley AA; Wiley JL; Craft RM
Drug Alcohol Depend; 2014 Oct; 143():22-8. PubMed ID: 25131716
[TBL] [Abstract][Full Text] [Related]
8. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
[TBL] [Abstract][Full Text] [Related]
9. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
[TBL] [Abstract][Full Text] [Related]
10. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
[TBL] [Abstract][Full Text] [Related]
11. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
Johnson JR; Lossignol D; Burnell-Nugent M; Fallon MT
J Pain Symptom Manage; 2013 Aug; 46(2):207-18. PubMed ID: 23141881
[TBL] [Abstract][Full Text] [Related]
12. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA
Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Langford RM; Mares J; Novotna A; Vachova M; Novakova I; Notcutt W; Ratcliffe S
J Neurol; 2013 Apr; 260(4):984-97. PubMed ID: 23180178
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
Jacobs DS; Kohut SJ; Jiang S; Nikas SP; Makriyannis A; Bergman J
Exp Clin Psychopharmacol; 2016 Oct; 24(5):320-330. PubMed ID: 27690502
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
Craft RM; Kandasamy R; Davis SM
Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
Britch SC; Craft RM
J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
[TBL] [Abstract][Full Text] [Related]
17. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
19. Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
Craft RM; Leitl MD
Eur J Pharmacol; 2008 Jan; 578(1):37-42. PubMed ID: 17905227
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
